iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

Glenmark Pharmaceuticals Ltd Option Chain

Add as a Preferred Source on Google
2,176.5
(0.48%)
Jun 8, 2026|05:30:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Ol (lots)Call PriceStrike PricePut PriceOl (lots)
1,1250%₹270 0%1,920₹5.7 4.58%54,37516%
3750%₹295.9 0%1,940₹8.85 0%3750%
--1,960₹6.95 -20.57%60,0000.62%
--1,980₹9.55 -12.38%16,5004.76%
25,1250%₹206.35 0%2,000₹13 3.17%1,49,250-0.25%
--2,020₹12.85 -6.88%10,1250%
--2,040₹18 -0.82%40,1250%
--2,060₹24.25 4.75%17,625-6%
3,3750%₹206.5 0%2,080₹29.45 9.88%19,87526.19%
1,8750%₹129.2 0%2,100₹33.95 4.14%1,27,8752.09%
--2,120₹42.6 11.51%28,12511.94%
22,8753.38%₹85.75 -7.59%2,140₹48.3 4.43%49,1251.55%
56,25011.11%₹74.5 -9.09%2,160₹56.95 5.36%2,83,8751.74%
90,750-6.56%₹65.15 -8.94%2,180₹69 9.35%97,5007.88%
5,74,12512.07%₹58.25 -5.74%2,200₹80.1 8.24%6,20,625-0.71%
67,87516.02%₹49 -7.54%2,220₹91.25 6.78%54,000-4%
1,41,7501.06%₹42 -7.79%2,240₹106.2 10.74%88,1250%
84,7500%₹35.75 -9.49%2,260₹104.6 -0.85%56,625-0.65%
53,6254.37%₹30.3 -9.14%2,280₹118.15 0%39,0000%
4,86,375-0.38%₹26.3 -7.06%2,300₹136 -3.68%2,01,3750.93%
79,500-4.50%₹21.8 -20.14%2,320₹161 2.54%1,06,5000%
1,29,3756.48%₹19.3 -6.08%2,340₹155 -0.41%40,500-2.70%
1,53,3753.54%₹16 -10.86%2,360₹175 0.57%1,14,0000%
98,625-1.12%₹16.75 12.04%2,380₹200.75 7.81%43,5000%
5,52,375-1.07%₹13.75 4.16%2,400₹240 8.15%1,79,625-7.17%
63,750-15.42%₹12.4 8.77%2,420₹232.95 0%45,3750%
26,25014.75%₹10.95 8.95%2,440₹129.55 0%3750%
41,250-5.98%₹9.55 -2.55%2,460₹285.8 0%3,7500%
26,2500%₹7.95 0%2,480₹179.6 0%2,6250%
6,49,500-2.31%₹7.8 8.33%2,500₹318 47.52%4,8750%
17,250-4.16%₹6.6 -29.03%2,520₹329 -3.87%1,1250%
7,8750%₹5.95 0%2,540--
24,00014.28%₹5.8 -0.85%2,560--
11,625-3.12%₹4.35 -22.32%2,580--
1,99,500-2.56%₹5 -2.91%2,600₹259 0%17,6250%
9,3754.16%₹3.45 -43.9%2,620--
12,3750%₹3.95 0%2,640₹316.3 0%3750%
21,7500%₹4 12.67%2,680₹326 0%19,1250%
74,6250.50%₹3 9.09%2,720₹496.2 0%1,1250%

Glenmark Pharma.: Related NEWS

Glenmark Pharma Q3 FY26 Profit Rises 16% to ₹403.2 Crore

Revenue from North America increased 24% year on year to ₹970.6 crore, including income from the out licensing of ISB 2001.

31 Jan 2026|02:22 PM
Read More
Top Stocks for Today - 25th September 2025

Here are some of the stocks that may see significant price movement today: Polycab India, Tata Steel, Dalmia Bharat, etc.

25 Sep 2025|06:57 AM
Read More
Top Stocks for Today - 23rd September 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Rail Vikas Nigam, Birla Corp, etc.

23 Sep 2025|07:01 AM
Read More
Glenmark subsidiary gets $700 Million in licensing deal; stock gains

At around 2.19 PM, Glenmark Pharma was trading 2.97% higher at ₹2,112.90 per piece, against the previous close of ₹2,051.90 on NSE.

9 Sep 2025|02:31 PM
Read More
Glenmark Pharma Q1 Net Profit Falls 86% YoY to ₹47 Crore

Operating performance was slightly weaker, with EBITDA dipping 1.4% to ₹580 crore from ₹588.2 crore.

18 Aug 2025|01:03 PM
Read More
Top Stocks for Today - 18th August 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharmaceuticals, Vedanta, Inox Wind, etc.

18 Aug 2025|08:14 AM
Read More
Glenmark Shares Surge 10% After AbbVie Inks Licensing Deal for ISB 2001

The compound is currently in Phase 1B clinical trials, being studied for multiple myeloma, a tough-to-treat form of blood cancer.

11 Jul 2025|09:48 AM
Read More
Top Stocks for Today - 11th July 2025

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

11 Jul 2025|07:20 AM
Read More
Top Stocks for Today - 26th May 2025

Here are some of the stocks that may see significant price movement today: Glenmark Pharma, Ashok Leyland, NTPC, etc.

26 May 2025|06:34 AM
Read More
Glenmark Pharma’s cancer drug receive FDA ‘fast track’ status

ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.

6 May 2025|09:31 AM
Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.